Back to GetFilings.com



Table of Contents



UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

     
þ
  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
    For the quarterly period ended March 31, 2004
 
o
  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
    For the transition period from           to

Commission file number 000-29273

Quovadx, Inc.

(Exact name of registrant as specified in its charter)
     
Delaware
  85-0373486
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

6400 S. Fiddler’s Green Circle, Suite 1000, Englewood, Colorado 80111

(Address of principal executive offices)

(303) 488-2019

(Registrant’s telephone number)

     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes þ          No o

      Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).     Yes þ          No o

      At July 31, 2004, 40,320,265 shares of common stock were outstanding.




QUOVADX, INC.

TABLE OF CONTENTS

                   
Page No.

     Financial Information        
       Condensed Consolidated Financial Statements     2  
         Condensed Consolidated Balance Sheets (unaudited) as of March 31, 2004 and December 31, 2003     2  
         Condensed Consolidated Statements of Operations (unaudited) for the three months ended March 31, 2004 and 2003     3  
         Condensed Consolidated Statements of Cash Flows (unaudited) for the three months ended March 31, 2004 and 2003     4  
         Notes to Condensed Consolidated Financial Statements     5  
       Management’s Discussion and Analysis of Financial Condition and Results of Operations     13  
       Quantitative and Qualitative Disclosures About Market Risk     27  
       Controls and Procedures     27  
     Other Information        
       Legal Proceedings     29  
       Changes in Securities and Use of Proceeds     32  
       Defaults Upon Senior Securities     32  
       Submission of Matters to a Vote of Security Holders     32  
       Other Information     32  
       Exhibits and Reports on Form 8-K     32  
 Signatures     33  
 Employment Agreement - Cory Isaacson
 Amendment No. 1 to the Employment Agreement - Cory Isaacson
 Asset Purchase Agreement
 Consulting Agreement dated April 1, 2003
 Certification of Acting Chief Executive Officer
 Certification of Acting Chief Financial Officer
 Certification of Acting Chief Executive Officer
 Certification of Acting Chief Financial Officer

EXPLANATORY NOTE

      This Quarterly Report on Form 10-Q for the period ending March 31, 2004, is being filed on the same date as the Form 10-Q for the period ending June 30, 2004 and Amendment No. 3 of our Form 10-K/A which restates our financial results for the years ended December 31, 2003 and 2002. These documents should be read in conjunction to fully understand the restatements contained in the Form 10-K/A and their impact on the information in this Form 10-Q.

1


Table of Contents

PART I: FINANCIAL INFORMATION

 
Item 1. Condensed Consolidated Financial Statements

QUOVADX, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

                       
March 31, December 31,
2004 2003


(In thousands, except for
share and per share amounts)
(Unaudited)
ASSETS
Current assets:
               
 
Cash and cash equivalents
  $ 13,982     $ 23,688  
 
Accounts receivable, net of allowance of $2,034 and $2,765, respectively
    15,744       17,593  
 
Unbilled accounts receivable
    3,126       3,465  
 
Other current assets
    4,288       4,304  
     
     
 
   
Total current assets
    37,140       49,050  
 
Property and equipment, net
    5,687       6,291  
 
Software, net
    22,954       28,876  
 
Other intangible assets, net
    16,555       17,735  
 
Goodwill
    47,206       48,015  
 
Other assets
    4,270       5,223  
     
     
 
   
Total assets
  $ 133,812     $ 155,190  
     
     
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
 
Current liabilities:
               
 
Accounts payable
  $ 2,325     $ 7,953  
 
Accrued liabilities
    12,581       15,881  
 
Unearned revenue
    18,469       19,066  
     
     
 
   
Total current liabilities
    33,375       42,900  
 
Deferred revenue
    315       315  
     
     
 
   
Total liabilities
    33,690       43,215  
     
     
 
Commitments and contingencies
               
Stockholders’ equity:
               
 
Preferred stock, $.01 par value, 5,000,000 shares authorized; no shares issued and outstanding
           
 
Common stock, $.01 par value; 100,000,000 authorized and 39,451,097 and 38,938,134 shares issued and outstanding, respectively
    395       389  
 
Additional paid-in capital
    269,625       269,011  
 
Unearned compensation
    (273 )     (385 )
 
Accumulated other comprehensive income
    330       131  
 
Accumulated deficit
    (169,955 )     (157,171 )
     
     
 
   
Total stockholders’ equity
    100,122       111,975  
     
     
 
     
Total liabilities and stockholders’ equity
  $ 133,812     $ 155,190  
     
     
 

The accompanying notes are an integral part of these condensed consolidated financial statements.

2


Table of Contents

QUOVADX, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                       
Three Months Ended
March 31,

2004 2003


(Restated)
(In thousands, except for
per share amounts)
(Unaudited)
Revenue:
               
 
Software license
  $ 7,406     $ 5,440  
 
Professional services
    4,561       4,554  
 
Recurring services
    11,699       7,539  
     
     
 
   
Total revenue
    23,666       17,533  
     
     
 
Cost of revenue:
               
 
Software license
    4,139       2,918  
 
Professional services
    4,278       3,065  
 
Recurring services
    6,292       4,889  
 
Asset impairments
    6,765        
     
     
 
   
Total cost of revenue
    21,474       10,872  
     
     
 
     
Gross profit
    2,192       6,661  
     
     
 
Operating expenses:
               
 
Sales and marketing
    6,534       3,842  
 
General and administrative
    3,693       3,030  
 
Research and development
    3,683       2,247  
 
Amortization of acquired intangibles
    1,182       457  
     
     
 
   
Total operating expenses
    15,092       9,576  
     
     
 
Loss from operations
    (12,900 )     (2,915 )
   
Interest income, net
    118       189  
     
     
 
Net loss
  $ (12,782 )   $ (2,726 )
     
     
 
Net loss per common share — basic and diluted
  $ (0.33 )   $ (0.09 )
     
     
 
Weighted average common shares outstanding — basic and diluted
    39,279       30,188  
     
     
 

The accompanying notes are an integral part of these condensed consolidated financial statements.

3


Table of Contents

QUOVADX, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

                       
Three Months Ended
March 31,

2004 2003


(Restated)
(In thousands)
(Unaudited)
Cash flows from operating activities
               
Net loss
  $ (12,782 )   $ (2,726 )
Adjustments to reconcile net loss to net cash used in operating activities:
               
 
Depreciation and amortization
    3,287       2,347  
 
Amortization of acquired intangibles
    840       457  
 
Amortization of deferred compensation
    253        
 
Asset impairment
    7,116        
 
Bad debt (recovery)/expense
    (445 )     275  
 
Change in assets and liabilities:
               
   
Accounts receivable
    2,609       (855 )
   
Unbilled accounts receivable
    339       (1,924 )
   
Other assets
    (1,417 )     (1,377 )
   
Accounts payable
    (5,628 )     452  
   
Accrued liabilities
    (2,752 )     2,067  
   
Unearned and deferred revenue
    (597 )     (536 )
     
     
 
     
Net cash used in operating activities
    (9,177 )     (1,820 )
     
     
 
Cash flows from investing activities
               
 
Purchase of property and equipment
    (313 )     (296 )
 
Capitalized software
    (837 )     (603 )
 
Sales of short-term investments
          10,912  
 
Purchases of short-term investments
          (638 )
     
     
 
     
Net cash (used in) provided by investing activities
    (1,150 )     9,375  
     
     
 
Cash flows from financing activities
               
 
Proceeds from issuance of common stock
    480       6  
     
     
 
     
Net cash provided by financing activities
    480       6  
     
     
 
Effect of foreign exchange rate changes on cash
    141        
     
     
 
Net (decrease) increase in cash and cash equivalents
    (9,706 )     7,561  
Cash and cash equivalents at beginning of period
    23,688       31,244  
     
     
 
Cash and cash equivalents at end of period
  $ 13,982     $ 38,805  
     
     
 

The accompanying notes are an integral part of these condensed consolidated financial statements.

4


Table of Contents

QUOVADX, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
1. Interim Financial Statements

      The accompanying condensed consolidated financial statements of Quovadx, Inc. (“Quovadx,” the “Company,” the “Registrant,” “we” or “us”) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to such rules and regulations. However, we believe that the disclosures are adequate to make the information presented not misleading. The unaudited financial statements have been prepared on the same basis as our annual financial statements and reflect all adjustments, which include only normal recurring adjustments necessary for a fair presentation in accordance with United States generally accepted accounting principles. The results for the three months ended March 31, 2004 are not necessarily indicative of the results expected for the full year. These financial statements should be read in conjunction with the audited financial statements and accompanying notes included in our Annual Report on Amendment No. 3 on Form 10-K/ A for the year ended December 31, 2003.

 
2. Effect of Restatements

      The financial results for the years ended December 31, 2003 and 2002 have been restated to properly account for transactions that were previously inaccurately reflected in the Company’s financial results. The cumulative effect of these restated financial statements increased the previously reported net loss by $1.8 million for the year ended December 31, 2003. These inaccuracies (a) overstated software license revenues due to the timing of delivery of software products and the accounting for certain reseller relationships (b) overstated professional services revenues due to the timing of adjustments to estimates used in determining the recognition of revenue under the percentage of completion method. The restatement also decreased current assets by $0.8 million and increased current liabilities by $1.0 million at December 31, 2003. A summary of the restatement impact on the three months ended March 31, 2003 is set forth below.

         
Three Months Ended
March 31, 2003

(In thousands except
per share amounts)
Increase in total revenue
  $ 100  
Decrease in net loss
    48  
Net loss per share
    0.00  
 
3. Net Loss per Common Share

      Net loss per common share (“EPS”) is calculated in accordance with Statement of Financial Accounting Standards (“SFAS”) No. 128, “Earnings per Share.” Under the provisions of SFAS No. 128, basic EPS is computed by dividing the net income for the period by the weighted average number of common shares outstanding during the period. Diluted EPS reflects the potential dilution that could occur if stock options were exercised, resulting in the issuance of common stock that would share in the earnings of the Company. Potential dilution of the stock options exercisable into common stock is computed using the treasury stock method based on the average fair market value of the stock. In periods where the Company has a net loss, the effect of all common stock equivalents is excluded from the computation of diluted EPS since their effect would decrease the loss per share. The diluted weighted average common shares calculation for the three months ended March 31, 2004 and 2003 excludes 834,701 and 457,895 options, respectively, to purchase common stock because their effect would have been anti-dilutive under the treasury stock method and excludes all options to purchase common stock because their effect would have been anti-dilutive to the net loss.

5


Table of Contents

QUOVADX, INC.
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
 
4. Asset Impairments

      In the first quarter of 2004, the Company incurred impairment charges totaling $7.1 million. Impairment charges totaling $6.8 million were recorded as a component of cost of revenue and the remaining $0.3 million was recorded within amortization of intangible assets. The Company wrote down $4.4 million of its internally developed and acquired capitalized software related to certain discontinued products. The Company’s decision to discontinue or suspend the development of these products resulted from a review conducted by the new management to refocus the Company’s resources to products that will generate revenues in the near term and conserve cash flows. Based on this review, certain internally developed and acquired software assets were deemed impaired because projected cash flows did not exceed the net book value of the asset.

      In the fourth quarter of 2003, the Company prepaid $0.9 million to Infotech Network Group (“Infotech”) for professional services. In March 2004, the Company prepaid Infotech an additional $2.1 million for professional services. Payments totaling $1.7 million were written off in the first quarter of 2004 because the asset was deemed not recoverable due to Infotech’s inability to provide assurances that it can deliver those services in the future. The Company expensed $0.4 million of prepaid services to cost of sales and research and development related to services Infotech provided in the first quarter of 2004.

      The Company also wrote down $0.7 million of deferred costs related to its transaction business. The deferred costs were written down to their expected realizable value because the total balance of the asset was not recoverable due to the cancellation of certain contracts and lower than expected revenues on other contracts. As of March 31, 2004, the Company had remaining deferred costs relating to its transaction business totaling $0.6 million.

 
5. Acquisitions

      On December 19, 2003, Quovadx purchased the outstanding stock of Rogue Wave Software, Inc. (“Rogue Wave”). Rogue Wave develops, markets and supports object-oriented and infrastructure software technology. The acquisition, structured as an exchange offer, provided that Quovadx acquire all of the outstanding stock of Rogue Wave for $4.09 in cash and 0.5292 of a share of Quovadx common stock for each share of Rogue Wave Common Stock. The total purchase price for this acquisition was $79.1 million, including 5,656,670 shares of Quovadx common stock, cash of $8.0 million, net of cash acquired, and $3.9 million in merger-related costs.

      The Company has retained an independent appraiser to assist with assigning the fair values to the identifiable intangibles acquired from Rogue Wave. The appraisal is expected to be completed by the third quarter of 2004. The preliminary estimate of goodwill, software and identifiable intangible assets acquired is $34.4 million, $10.6 million and $4.6 million, respectively. The Company has not completed its allocation of goodwill by reporting segment. The Company expects to complete the allocation in the third quarter of 2004. The amount of goodwill that will be assigned to a reporting unit will be determined by allocating the purchase price to the assets and liabilities of each reporting unit. The goodwill recognized in the Rogue Wave acquisition is not subject to amortization but will be tested for impairment annually or more frequently if events or changes in circumstances indicate the asset might be impaired. The identifiable intangible assets will be amortized over their estimated lives.

      On September 19, 2003, Quovadx consummated the acquisition of CareScience, Inc. CareScience stockholders received a fixed exchange rate of $1.40 cash and 0.1818 shares of Quovadx’s common stock for each share of CareScience common stock they owned. The purchase price totaling $30.1 million included 2,415,900 shares of Quovadx common stock issued in exchange for all outstanding shares of CareScience capital stock, cash of $4.7 million, net of cash acquired, and $2.3 million in merger-related costs, including transaction fees and stock option payout. The Company retained an independent appraiser to assist with the assigning of the fair values to the identifiable intangibles acquired from CareScience. The acquisition

6


Table of Contents

QUOVADX, INC.
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

generated goodwill, software and customer base intangible assets acquired of $12.8 million, $0.8 million and $8.6 million, respectively.

      The unaudited pro forma results of operations as though the Rogue Wave and CareScience acquisitions had been completed as of January 1, 2003 are as follows (in thousands except for per share amounts):

         
Three Months Ended
March 31, 2003

Revenues
  $ 29,118  
Net Loss
    (4,664 )
Net Loss per share
    (0.12 )
 
6. Segment Information

      Segment information has been prepared in accordance with SFAS No. 131, “Disclosures about Segments of an Enterprise and Related Information.” The Company defines operating segments as components of an enterprise for which discrete financial information is available and is reviewed regularly by the chief operating decision-maker or decision-making group, to evaluate performance and make operating decisions. The chief operating decision-making group reviews the revenue and margin by the nature of the services provided and reviews the overall results of the Company. Accounting policies of the segments are the same as those described in the summary of significant accounting policies in the Company’s Annual Report on Form 10-K/A, Amendment 3 for the year ended December 31, 2003.

      The Company operates in three segments: software license, professional services, and recurring revenue. The software license segment includes revenue from software license sales and software subscriptions. The professional services segment includes revenue generated from software implementation, development, and integration. The recurring revenue segment includes revenue generated from outsourcing, hosting, software maintenance, transactions, and other recurring services. The segment information for the three months ended March 31, 2004 is reflected in the condensed consolidated statements of operations.

 
7. Goodwill and Other Intangible Assets

      Intangible assets recognized in the Company’s acquisitions are being amortized over their estimated lives ranging from three to eight years. The following table provides information relating to the Company’s intangible assets as of March 31, 2004):

                           
Accumulated
Cost Amortization Total



(In thousands)
Amortizable intangible assets:
                       
 
Customer base
  $ 19,002     $ (3,044 )   $ 15,958  
 
Tradenames
    465       (67 )     398  
 
Other
    2,224       (2,025 )     199  
     
     
     
 
 
Total
  $ 21,691     $ (5,136 )   $ 16,555  
     
     
     
 

7


Table of Contents

QUOVADX, INC.
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
                           
Rogue Wave CareScience Total



Goodwill:
                       
 
Balance at December 31, 2003
  $ 34,697     $ 13,318     $ 48,015  
 
Reconciliation of opening balances
    (866 )     (194 )     (1,060 )
 
Acquisition expenses
          (357 )     (357 )
 
Lease restructu